Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2003-10-14
2008-12-16
Benzion, Gary (Department: 1637)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091100
Reexamination Certificate
active
07465542
ABSTRACT:
Methods are provided for determining whether a patient treated with an anti-proliferative agent is susceptible to toxicity. In practicing the subject methods, an expression profile for the transcriptional response to a therapy is obtained from the patient and compared to a reference profile to determine whether the patient is susceptible to toxicity. In addition, reagents and kits thereof that find use in practicing the subject methods are provided.
REFERENCES:
patent: 6015673 (2000-01-01), Gonzalez et al.
patent: 6251362 (2001-06-01), Wahl et al.
patent: 2003/0165954 (2003-09-01), Katagiri et al.
patent: 2004/0018527 (2004-01-01), Chang et al.
patent: WO 01/84139 (2001-11-01), None
Komarova et al. Oncogene vol. 17:1089-1096. 1998.
Tibshirani et al. PNAS vol. 99:6567-6572. 2002.
Barber et al., Relatinship Between in Vitro Chromosomal Readiosensitivity of Peripheral Blood Lymphocytes and the Expression of Normal Tissue Damage Following Radiotherapy for Breast Cancer, (2002), Radiother Oncol, 55:179-86.
Brock et al., In Vitro Radiosensitvity and Normal Tissue Damage, (2000), Radiother Oncol, 55:93-94.
Crompton et al., Altered Apoptotic Profiles in Irradiated Patients with Increased Toxicity, (1999), Int J Radiat Oncol Biol Phys, 45:707-714.
Johansen et al., Relationship Between the In Vitro Radiosensitivity of Skin Fibroblasts and the Expression of Subcutaneous Fibrosis, Telangiectasia, and Skin Erythema After Radiotherapy, (1996), Radiother Oncol, 40:101-9.
Peacock et al., Cellular Radiosensitvity and Complication Risk After Curative Radiotherapy, (2000), Radiother Oncol, 55:173-8.
Russell et al., Low Predictive Value of Intrinsic Fibroblast Radiosensitvity for Fibrosis Developemnt Following Radiotherapy for Breast Cancer, (1998), Int J Radiat Biol, 73:661-70.
Tibshirani et al., Diagnosis of Multiple Cancer Types by Shrunken Centroids of Gene Expression, (2002) Proc. Natl. Acad. Sci. 99:6567-6572.
Tusher et al., Significance Analysis of Microarrays Applied to the Ionizing Radiation Response, (2001), Proc. Natl. Acad. Sci., 98:5116-5121.
Chu Gilbert
Hong Wan-Jen
Rieger Kerri Elyse
Tang Jean
Tibshirani Robert
Benzion Gary
Bozicevic Field & Francis LLP
Calamita Heather G
Sherwood Pamela J.
The Board of Trustees of the Leland Stanford Junior University
LandOfFree
Methods and compositions for determining risk of treatment... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for determining risk of treatment..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for determining risk of treatment... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4028574